Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.
Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P less than 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conduc...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245100/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2069389/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.780 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|